Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy

World Journal of Gastroenterology

Volumn 12, Issue 18, 2006, Pages 2969-2978

  Grover, V P Bob ^a,b   Dresner, M Alex ^b   Forton, Daniel M ^a   Counsell, Serena ^b   Larkman, David J ^b   Patel, Nayna ^a,b   Thomas, Howard C ^a   Taylor Robinson, Simon D ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Arterial spin labeling; Diffusion weighted imaging; Functional MRI; Hepatic encephalopathy; Magnetic resonance imaging; Magnetic resonance spectroscopy

Indexed keywords

AMMONIA; GLUTAMIC ACID; GLUTAMINE; INOSITOL;

ANISOTROPY; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN SIZE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; DISEASE SEVERITY; EDITORIAL; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEPATIC ENCEPHALOPATHY; HOMEOSTASIS; HUMAN; HYPERAMMONEMIA; LIVER FAILURE; MENTAL DISEASE; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOGENESIS; PATIENT MONITORING; PROTON NUCLEAR MAGNETIC RESONANCE; VOLUMETRY; WATER CONTENT;

EID: 33744537598     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i19.2969     Document Type: Editorial

References (98)

1. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-721
2. Conn HO. Diuresis of ascites: fraught with or free from hazard. Gastroenterology 1977; 73: 619-621
3. Butterworth RF, Giguere JF, Michaud J, Lavoie J, Layrargues GP. Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol 1987; 6:1-12
4. Schenker S, Brady CE. Pathogenesis of hepatic encephalopathy. Conn, HO and Bircher, J. Hepatic Encephalopathy: Syndromes and Therapies. Bloomington: Medi-Ed Press,1994: 43-61
5. Haussinger D, Kircheis G, Fischer R, Schliess F, vom Dahl S. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? J Hepatol 2000; 32: 1035-1038
6. Lee K, Moller L, Hardt F, Haubek A, Jensen E. Alcohol-in-duced brain damage and liver damage in young males. Lancet 1979; 2: 759-761
7. Charness ME. Brain lesions in alcoholics. Alcohol Clin Exp Res 1993; 17: 2-11
8. Zeneroli ML, Cioni G, Crisi G, Vezzelli C, Ventura E. Globus pallidus alterations and brain atrophy in liver cirrhosis patients with encephalopathy: an MR imaging study. Magn Reson Imaging 1991; 9: 295-302
9. Taylor-Robinson SD, Oatridge A, Hajnal JV, Burroughs AK, McIntyre N, deSouza NM. MR imaging of the basal ganglia in chronic liver disease: correlation of T1-weighted and magnetisation transfer contrast measurements with liver dysfunction and neuropsychiatric status. Metab Brain Dis 1995; 10: 175-188
10. Krieger D, Krieger S, Jansen O, Gass P, Theilmann L, Lichtnecker H. Manganese and chronic hepatic encephalopathy. Lancet 1995; 346: 270-274
11. Pujol J, Kulisevsky J, Moreno A, Deus J, Alonso J, Balanzo J, Marti-Vilalta JL, Capdevila A. Neurospectroscopic alterations and globus pallidus hyperintensity as related magnetic resonance markers of reversible hepatic encephalopathy. Neurology 1996; 47: 1526-1530
12. Dietz MC, Ihrig A, Wrazidlo W, Bader M, Jansen O, Triebig G. Results of magnetic resonance imaging in long-term manganese dioxide-exposed workers. Environ Res 2001; 85: 37-40
13. Mirowitz SA, Westrich TJ. Basal ganglial signal intensity alterations: reversal after discontinuation of parenteral manganese administration. Radiology 1992; 185:535-536
14. Spahr L, Butterworth RF, Fontaine S, Bui L, Therrien G, Milette PC, Lebrun LH, Zayed J, Leblanc A, Pomier-Layrargues G. Increased blood manganese in cirrhotic patients: relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. Hepatology 1996; 24: 1116-1120
15. Hauser RA, Zesiewicz TA, Martinez C, Rosemurgy AS, Olanow CW. Blood manganese correlates with brain magnetic resonance imaging changes in patients with liver disease. Can J Neurol Sci 1996; 23: 95-98
16. Maeda H, Sato M, Yoshikawa A, Kimura M, Sonomura T, Terada M, Kishi K. Brain MR imaging in patients with hepatic cirrhosis: relationship between high intensity signal in basal ganglia on T1-weighted images and elemental concentrations in brain. Neuroradiology 1997; 39: 546-550
17. Krieger S, Jauss M, Jansen O, Theilmann L, Geissler M, Krieger D. Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis. Gastroenterology 1996; 111: 147-155
18. Thuluvath PJ, Edwin D, Yue NC, deVilliers C, Hochman S, Klein A. Increased signals seen in globus pallidus in T1-weighted magnetic resonance imaging in cirrhotics are not suggestive of chronic hepatic encephalopathy. Hepatology 1995; 21:440-442
19. Rose C, Butterworth RF, Zayed J, Normandin L, Todd K, Michalak A, Spahr L, Huet PM, Pomier-Layrargues G. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 1999; 117: 640-644
20. Rodriguez-Moreno F, Gonzalez-Reimers E, Santolaria-Fernandez F, Galindo-Martin L, Hernandez-Torres O, Batista-Lopez N, Molina-Perez M. Zinc, copper, manganese, and iron in chronic alcoholic liver disease. Alcohol 1997; 14: 39-44
21. Wijdicks EF, Plevak DJ, Rakela J, Wiesner RH. Clinical and radiologic features of cerebral edema in fulminant hepatic failure. Mayo Clin Proc 1995; 70: 119-124
22. Cordoba J, Alonso J, Rovira A, Jacas C, Sanpedro F, Castells L, Vargas V, Margarit C, Kulisewsky J, Esteban R, Guardia J. The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J Hepatol 2001; 35: 598-604
23. Rovira A, Grive E, Pedraza S, Rovira A, Alonso J. Magnetization transfer ratio values and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis. AJNR Am J Neuroradiol 2001; 22: 1137-1142
24. Rovira A, Cordoba J, Sanpedro F, Grive E, Rovira-Gols A, Alonso J. Normalization of T2 signal abnormalities in hemispheric white matter with liver transplant. Neurology 2002; 59: 335-341
25. Hajnal JV, Baudouin CJ, Oatridge A, Young IR, Bydder GM. Design and implementation of magnetization transfer pulse sequences for clinical use. J Comput Assist Tomogr 1992; 16: 7-18
26. Wolff SD, Balaban RS. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med 1989; 10: 135-144
27. van Buchem MA, Tofts PS. Magnetization transfer imaging. Neuroimaging Clin N Am 2000; 10: 771-88, ix
28. Cordoba J, Sanpedro F, Alonso J, Rovira A. 1H magnetic resonance in the study of hepatic encephalopathy in humans. Metab Brain Dis 2002; 17: 415-429
29. Iwasa M, Kinosada Y, Nakatsuka A, Watanabe S, Adachi Y. Magnetization transfer contrast of various regions of the brain in liver cirrhosis. AJNR Am J Neuroradiol 1999; 20: 652-654
30. Forton DM, Patel N, Prince M, Oatridge A, Hamilton G, Goldblatt J, Allsop JM, Hajnal JV, Thomas HC, Bassendine M, Jones DE, Taylor-Robinson SD. Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels. Gut 2004; 53: 587-592
31. Moseley ME, Kucharczyk J, Mintorovitch J, Cohen Y, Kurhanewicz J, Derugin N, Asgari H, Norman D. Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. AJNR Am J Neuroradiol 1990; 11: 423-429
32. Baird AE, Warach S. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab 1998; 18: 583-609
33. Larsson HB, Thomsen C, Frederiksen J, Stubgaard M, Henriksen O. In vivo magnetic resonance diffusion measurement in the brain of patients with multiple sclerosis. Magn Reson Imaging 1992; 10: 7-12
34. Stadnik TW, Chaskis C, Michotte A, Shabana WM, van Rompaey K, Luypaert R, Budinsky L, Jellus V, Osteaux M. Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings. AJNR Am J Neuroradiol 2001; 22: 969-976
35. Kono K, Inoue Y, Nakayama K, Shakudo M, Morino M, Ohata K, Wakasa K, Yamada R. The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 2001; 22:1081-1088
36. Doran M, Hajnal JV, Van Bruggen N, King MD, Young IR, Bydder GM. Normal and abnormal white matter tracts shown by MR imaging using directional diffusion weighted sequences. J Comput Assist Tomogr 1990; 14: 865-873
37. Chenevert TL, Brunberg JA, Pipe JG. Anisotropic diffusion in human white matter: demonstration with MR techniques in vivo. Radiology 1990; 177:401-405.
38. Basser PJ, Jones DK. Diffusion-tensor MRI: theory, experimental design and data analysis - a technical review. NMR Biomed 2002; 15: 456-467
39. Basser PJ, Mattiello J, LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys J 1994; 66: 259-267
40. Mori S, van Zijl P. MR tractography using diffusion tensor imaging. Gillard J, Waldman A, and Barker PB Clinical MR Neuroimaging. 1st ed. Cambridge University Press, 2005: 86-98
41. Mori S, Barker PB. Diffusion magnetic resonance imaging: its principle and applications. Anat Rec 1999; 257: 102-109
42. Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: Application to diffusion and perfusion in neurologic disorders. Radiology 1986; 161: 401-407
43. Jones DK. Fundamentals of diffusion MR imaging. Gillard J, Waldman A, and Barker PB Clinical MR Neuroirnaging. Cambridge University Press, 2005: 54-85
44. Beaulieu C. The basis of anisotropic water diffusion in the nervous system - a technical review. NMR Biomed 2002; 15: 435-455
45. Lodi R, Tonon C, Stracciari A, Weiger M, Camaggi V, Iotti S, Donati G, Guarino M, Bolondi L, Barbiroli B. Diffusion MRI shows increased water apparent diffusion coefficient in the brains of cirrhotics. Neurology 2004; 62: 762-766
46. Parsons-Smith BG, Summerskill WH, Dawson AM, Sherlock S. The electroencephalograph in liver disease. Lancet 1957; 273: 867-871
47. Davies MG, Rowan MJ, Feely J. EEG and event related potentials in hepatic encephalopathy. Metab Brain Dis 1991; 6: 175-186
48. Timmermann L, Gross J, Butz M, Kircheis G, Haussinger D, Schnitzler A. Pathological oscillatory coupling within the human motor system in different tremor syndromes as revealed by magnetoencephalography. Neurol Clin Neurophysiol 2004; 2004:26
49. Lockwood AH. Positron emission tomography in the study of hepatic encephalopathy. Metab Brain Dis 2002; 17:431-435
50. Lockwood AH. Positron emission tomography in the study of hepatic encephalopathy. Metab Brain Dis 1998; 13:303-309
51. Jalan R, Turjanski N, Taylor-Robinson SD, Koepp MJ, Richardson MP, Wilson JA, Bell JD, Brooks DJ. Increased availability of central benzodiazepine receptors in patients with chronic hepatic encephalopathy and alcohol related cirrhosis. Gut 2000; 46: 546-552
52. Cagnin A, Taylor-Robinson SD, Forton DM, Banati RB. In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy. Gut 2006; 55: 547-553
53. Jezzard P. Functional MRI. Tofts PS. Quantitative MRI of the Brain. 1 ed. Wiley, 2003:413-53
54. Ogawa S, Tank DW, Menon R, Ellermann JM, Kim SG, Merkle H, Ugurbil K. Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging. Proc Natl Acad Sci USA 1992; 89: 5951-5955
55. Kwong KK, Belliveau JW, Chesler DA, Goldberg IE, Weisskoff RM, Poncelet BP, Kennedy DN, Hoppel BE, Cohen MS, Turner R. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci USA 1992; 89: 5675-5679
56. Pauling L, Coryell C. The Magnetic Properties and Structure of Hemoglobin, Oxyhemoglobin and Carbon Monoxyhemoglobin. Proc Natl Acad Sci USA 1936; 22(4): 210-216
57. Fox PT, Raichle ME, Mintun MA, Dence C. Nonoxidative glucose consumption during focal physiologic neural activity. Science 1988; 241:462-464
58. Fox PT, Raichle ME. Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc Natl Acad Sci USA 1986; 83: 1140-1144
59. Zafiris O, Kircheis G, Rood HA, Boers F, Haussinger D, Zilles K. Neural mechanism underlying impaired visual judgement in the dysmetabolic brain: an fMRI study. Neuroimage 2004; 22: 541-552
60. Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Haussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 2002; 35: 357-366
61. Iwasa M, Matsumura K, Kaito M, Ikoma J, Kobayashi Y, Nakagawa N, Watanabe S, Takeda K, Adachi Y. Decrease of regional cerebral blood flow in liver cirrhosis. Eur J Gastroenterol Hepatol 2000; 12: 1001-1006
62. Yang Y, Frank JA, Hou L, Ye FQ McLaughlin AC, Duyn JH. Multislice imaging of quantitative cerebral perfusion with pulsed arterial spin labeling. Magn Reson Med 1998; 39: 825-832
63. Golay X, Hendrikse J, Lim TC. Perfusion imaging using arterial spin labeling. Top Magn Reson Imaging 2004; 15:10-27
64. Calamante F. Bolus dispersion issues related to the quantification of perfusion MRI data. J Magn Reson Imaging 2005; 22: 718-722
65. Oatridge A. The use of subvoxel image registration and subtraction of serial magnetic resonance imaging for detecting small changes to the brain. Leeds: Leeds Metropolitan University; 1998: 96-116
66. Saeed N. Magnetic resonance image segmentation using pattern recognition, and applied to image registration and quantitation. NMR Biomed 1998; 11: 157-167
67. Oatridge A, Barnard ML, Puri BK, Taylor-Robinson SD, Hajnal JV, Saeed N, Bydder GM. Changes in brain size with treatment in patients with hyper- or hypothyroidism. AJNR Am J Neuroradiol 2002; 23: 1539-1544
68. Oatridge A, Holdcroft A, Saeed N, Hajnal JV, Puri BK Fusi L, Bydder GM. Change in brain size during and after pregnancy: study in healthy women and women with preeclampsia. AJNR Am J Neuroradiol 2002; 23: 19-26
69. Saeed N, Puri BK, Oatridge A, Hajnal JV, Young IR. Two methods for semi-automated quantification of changes in ventricular volume and their use in schizophrenia. Magn Reson Imaging 1998; 16:1237-1247
70. Hajnal JV, Hill DLG, Hawkes DJ, Medical Image Registration. In: The Biomedical Engineering Series. CRC Press, 2001: 143-182
71. Patel N, White S, Dhanjal NS, Oatridge A, Taylor-Robinson SD. Changes in brain size in hepatic encephalopathy: a coregistered MRI study. Metab Brain Dis 2004; 19:431-445
72. Testa C, Gomez-Anson B, Gines P, Torre A, Alayrach E, Frisoni G. Brain changes in cirrhosis: A voxel based morphometry study. Proceedings of the 11th Annual Meeting of the Organization for Human Brain Mapping; 2005. Abstract No. 475
73. Harper C, Corbett D. Changes in the basal dendrites of cortical pyramidal cells from alcoholic patients - a quantitative Golgi study. J Neurol Neurosurg Psychiatry 1990; 53: 856-861
74. Shah NJ, Zaitsev M, Steinhoff S, Zilles K. A new method for fast multislice T(1) mapping. Neuroimage 2001; 14: 1175-1185
75. Steinhoff S, Zaitsev M, Zilles K, Shah NJ. Fast T(1) mapping with volume coverage. Magn Reson Med 2001; 46:131-140
76. Neeb H, Kircheis G, Haussinger D, Zilles K, Shah NJ. Quantitative Measurement of Absolute Water Content in Hepatic Encephalopathy. Proceedings of the International Society of Magnetic Resonance in Medicine [13], 1060; 2005
77. Ross B, Kreis R, Ernst T. Clinical tools for the 90s: magnetic resonance spectroscopy and metabolite imaging. Eur J Radiol 1992; 14: 128-140
78. Chamuleau RA, Bosman DK, Bovee WM, Luyten PR, den Hollander JA. What the clinician can learn from MR glutamine/glutamate assays. NMR Biomed 1991; 4:103-108
79. Kreis R, Ross BD, Farrow NA, Ackerman Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 1992; 182: 19-27
80. Ross BD, Jacobson S, Villamil F, Korula J, Kreis R, Ernst T, Shonk T, Moats RA. Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 1994; 193: 457-463
81. Haussinger D, Laubenberger J, vom Dahl S, Ernst T, Bayer S, Langer M, Gerok W, Hennig J. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology 1994; 107:1475-1480
82. Taylor-Robinson SD, Sargentoni J, Marcus CD, Morgan MY, Bryant DJ. Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab Brain Dis 1994; 9: 347-359
83. Taylor-Robinson SD, Sargentoni J, Oatridge A, Bryant DJ, Hajnal JV, Marcus CD, Seery JP, Hodgson HJ, deSouza NM. MR imaging and spectroscopy of the basal ganglia in chronic liver disease: correlation of T1-weighted contrast measurements with abnormalities in proton and phosphorus-31 MR spectra. Metab Brain Dis 1996; 11: 249-268
84. Taylor-Robinson SD, Buckley C, Changani KK, Hodgson HJ, Bell JD. Cerebral proton and phosphorus-31 magnetic resonance spectroscopy in patients with subclinical hepatic encephalopathy. Liver 1999; 19: 389-398
85. Laubenberger J, Haussinger D, Bayer S, Gufler H, Hennig J, Langer M. Proton magnetic resonance spectroscopy of the brain in symptomatic and asymptomatic patients with liver cirrhosis. Gastroenterology 1997; 112: 1610-1616
86. Miller BL. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 1991; 4: 47-52
87. Bluml S, Zuckerman E, Tan J, Ross BD. Proton-decoupled 31P magnetic resonance spectroscopy reveals osmotic and metabolic disturbances in human hepatic encephalopathy. J Neurochem 1998; 71: 1564-1576
88. Bottomley PA, Hart HR Jr, Edelstein WA, Schenck JF, Smith LS, Leue WM, Mueller OM, Redington RW. Anatomy and metabolism of the normal human brain studied by magnetic resonance at 1.5 Tesla. Radiology 1984; 150: 441-446
89. 31p MRS in patients with chronic liver disease. Proceedings of the 11th Annual Meeting of the Society of Magnetic Resonance in Medicine, 1992;3:1919
90. Patel N, Forton DM, Coutts GA, Thomas HC, Taylor-Robinson SD. Intracellular pH measurements of the whole head and the basal ganglia in chronic liver disease: a phosphorus-31 MR spectroscopy study. Metab Brain Dis 2000; 15: 223-240
91. Taylor-Robinson SD, Sargentoni J, Oatridge A, Bryant DJ, Hajnal JV, Marcus CD, Seery JP, Hodgson HJ, deSouza NM. MR imaging and spectroscopy of the basal ganglia in chronic liver disease: correlation of T1-weighted contrast measurements with abnormalities in proton and phosphorus-31 MR spectra. Metab Brain Dis 1996; 11: 249-268
92. Taylor-Robinson SD, Sargentoni J, Mallalieu RJ, Bell JD, Bryant DJ, Coutts GA, Morgan MY. Cerebral phosphorus-31 magnetic resonance spectroscopy in patients with chronic hepatic encephalopathy. Hepatology 1994; 20: 1173-1178
93. Binesh N, Huda A, Bugbee M, Gupta R, Rasgon N, Kumar A, Green M, Han S, Thomas MA. Adding another spectral dimension to 1H magnetic resonance spectroscopy of hepatic encephalopathy. J Magn Reson Imaging 2005; 21: 398-405
94. Lei H, Peeling J. A localized double-quantum filter for in vivo detection of taurine. Magn Reson Med 1999; 42: 454-460
95. Shen J, Yang J, Choi IY, Li SS, Chen Z. A new strategy for in vivo spectral editing. Application to GABA editing using selective homonuclear polarization transfer spectroscopy. J Magn Reson 2004; 170: 290-298
96. Choi C, Ogilvie CJ, Malykhin N, Ngo JT, Hartfeil MA, Coupland NJ. Detection of the myo-inositol 4.06-ppm resonance by selective J rewinding: application to human prefrontal cortex in vivo. Magn Reson Med 2005; 54:1536-1540
97. Hurd R, Sailasuta N, Srinivasan R, Vigneron DB, Pelletier D, Nelson SJ. Measurement of brain glutamate using TE-aver-aged PRESS at 3T. Magn Reson Med 2004; 51: 435-440
98. Srinivasan R, Sailasuta N, Hurd R, Nelson S, Pelletier D. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain 2005; 128: 1016-1025